Arcturus appoints former Merck Global Vaccines President John Markels to board

Arcturus Therapeutics Holdings Inc.

John Markels, Ph.D., appointed to Board of Directors effective December 8, 2022.
Markels most recently President of Global Vaccines at Merck; retired March 2022 after 35 years.
He will provide strategic oversight to Arcturus' vaccine franchise and manufacturing processes.
Markels also serves on the board of Sangamo Therapeutics.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John Markels

Director

ARCT · Arcturus Therapeutics Holdings Inc.

Effective: 2022-12-08
Filed: December 13, 2022, 6:59 PM ET

On December 8, 2022, Dr. John Markels agreed to serve as a member of the Board of Directors of Arcturus Therapeutics Holdings Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Markels was appointed as Director at Arcturus Therapeutics Holdings Inc..

Action: appointed
Role: Director

Exact text from the filing

On December 8, 2022, Dr. John Markels agreed to serve as a member of the Board of Directors of Arcturus Therapeutics Holdings Inc.

View on SEC.gov

Arcturus Therapeutics Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001193805-22-001719

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.